Revenue: $647.9 million in QQ2 2025, YoY +23.41%, QoQ +3.18%
Gross Profit: $499.402 million, Gross Margin 77.08% (YoY +22.67%, QoQ +2.65%)
Operating Income: -$40.14 million, Operating Margin -6.20% (YoY improvement but QoQ a sharp decline of -30.89%)
Net Income: -$7.724 million, Net Margin -1.19% (YoY improvement of +72.87%, QoQ +35.91%)
EPS (Diluted): -$0.0503
EBITDA: $13.553 million, EBITDA Margin 2.09%
Depreciation & Amortization: $28.733 million
Stock-Based Compensation: $172.117 million (major driver of opEX)
Operating Expenses: $539.542 million; Cost & Expenses: $688.040 million
R&D: $170.860 million (≈26.4% of revenue)
SG&A: $608.100 thousand G&A + $307.447 million SG&A (S&M) total ≈ $376.? million; SG&A intensity remains high relative to revenue
Net Cash Provided by Operating Activities: $179.433 million
Free Cash Flow: $143.428 million
Cash, Cash Equivalents: $1,758.506 million; Short-Term Investments: $1,121.734 million; Total Cash & ST Investments: $2,880.240 million
Total Assets: $5,005.968 million; Total Liabilities: $3,398.622 million; Total Stockholders’ Equity: $1,607.346 million
Net Debt: -$520.164 million (Net cash position); Current Ratio: 1.15; Quick Ratio: 1.15; Cash Ratio: 0.58
Deferred Revenue: $1,595.78 million (significant source of future revenue visibility)
Capital Expenditures: $36.005 million; Free Cash Flow Yield: ~22.1% of revenue